Analysis Waking up from the DREAM of preventing diabetes with drugs BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39169.447488.94 (Published 26 April 2007) Cite this as: BMJ 2007;334:882 Article Related content Metrics Responses Peer review Related articles Education And Debate Selling sickness: the pharmaceutical industry and disease mongeringCommentary: Medicalisation of risk factors Published: 13 April 2002; BMJ 324 doi:10.1136/bmj.324.7342.886 Education And Debate Who needs health care—the well or the sick? Published: 21 April 2005; BMJ 330 doi:10.1136/bmj.330.7497.954 Education And Debate Validity of composite end points in clinical trials Published: 10 March 2005; BMJ 330 doi:10.1136/bmj.330.7491.594 Feature Surrogates under scrutiny: fallible correlations, fatal consequences Published: 15 August 2011; BMJ 343 doi:10.1136/bmj.d5160 Education And Debate Users' guide to detecting misleading claims in clinical research reports Published: 04 November 2004; BMJ 329 doi:10.1136/bmj.329.7474.1093 See more Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test BMJ March 25, 2024, 384 q744; DOI: https://doi.org/10.1136/bmj.q744 FDA approves first over-the-counter blood glucose monitor for diabetes BMJ March 11, 2024, 384 q611; DOI: https://doi.org/10.1136/bmj.q611 US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes, says FDA BMJ March 06, 2024, 384 q569; DOI: https://doi.org/10.1136/bmj.q569 Scarlett McNally: Preventing obesity is different from curing it—and even more urgent BMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134 Artificial pancreases for type 1 diabetes: Better access is “watershed moment”—but delivery is key BMJ January 23, 2024, 384 q102; DOI: https://doi.org/10.1136/bmj.q102 Cited by... Surrogates under scrutiny: fallible correlations, fatal consequencesFulltext PDF The concept of prevention: a good idea gone astray?Fulltext PDF Abstract Screening for and prevention of type 2 diabetesFulltext PDF Abstract
